Are the current definitions of impaired glucose tolerance (IGT) and impaired fasting glycemia (IFG) appropriate? Are IFG and IGT risk factors, risk markers or diseases? These are just a couple of the questions addressed.
Read More »Issue 131 Item 4 Ramipril Helps Prevent Diabetes & Cardiovascular Events, Among
Treatment with the ACE inhibitor ramipril may help prevent the development of diabetes as well as lower the risk of heart attack, stroke, and cardiovascular mortality in patients at high risk for cardiovascular events.
Read More »Issue 132 Item 3 ASPART VS. LISPRO and the Winner IS!
A group of researchers led by Dr Johannes Plank from the Karl-Franzens University of Graz in Austria, compared the pharmacokinetic and pharmacodynamic profiles of insulin aspart and insulin lispro and their effects on postprandial blood glucose excursions in patients with type 1 diabetes.
Read More »Issue 127 Item 4 A New Two-Step Screening Protocol for Type 2 Diabetes
OGTT was not required to identify the large majority of diabetic patients in this two-step screening procedure.”
Read More »Issue 128 Item 4 Even With Motivation Patients Fail to Change Life Style
Despite motivation, patients with diabetes still consuming high-fat diets, failing to exercise sufficiently
Read More »Issue 129 Item 4 Excess Fat Can Cancel Benefits of Exercise
Weight still matters, even if you put in time at the gym and are fit.
Read More »Issue 130 Item 4 ACE Inhibitor Plus Diuretic May Halt Coronary Events
Stroke patients see 38% reduction in risk of nonfatal MIs, 26% drop in CHF risk.
Read More »Issue 131 Item 3 Visceral Fat Linked To Peripheral And Hepatic Insulin Resistanc
Visceral adiposity is associated with both peripheral and hepatic insulin resistance, independent of gender, in the type 2 diabetic patients
Read More »Issue 132 Item 2 TZD’s Cut Myocardial Infarction Risk in Type 2’s
The use of thiazolidinediones as a strategy for blood glucose lowering in type 2 diabetics may be associated with a reduced risk of myocardial infarction (MI).
Read More »Issue 127 Item 3 Waist Size Not BMI is Key for Determining Risk for CVD and Diab
That according to 2 recent studies in the American Journal of Hypertension and Nutrition.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.